McLeod JF - Search Results

1

Proof of concept: a PhRMA position paper with recommendations for best practice.

Cartwright ME, Cohen S, Fleishaker JC, Madani S, McLeod JF, Musser B, Williams SA. Cartwright ME, et al. Among authors: mcleod jf. Clin Pharmacol Ther. 2010 Mar;87(3):278-85. doi: 10.1038/clpt.2009.286. Epub 2010 Feb 3. Clin Pharmacol Ther. 2010. PMID: 20130568

2

Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.

Krishna G, Moton A, Ma L, Savant I, Martinho M, Seiberling M, McLeod J. Krishna G, et al. Clin Ther. 2009 Feb;31(2):286-98. doi: 10.1016/j.clinthera.2009.02.022. Clin Ther. 2009. PMID: 19302901 Clinical Trial.

3

PhRMA survey on the conduct of first-in-human clinical trials under exploratory investigational new drug applications.

Karara AH, Edeki T, McLeod J, Tonelli AP, Wagner JA. Karara AH, et al. J Clin Pharmacol. 2010 Apr;50(4):380-91. doi: 10.1177/0091270009344987. Epub 2010 Jan 23. J Clin Pharmacol. 2010. PMID: 20097935

4

The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective.

Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, Ni L, Kumar G, McLeod J, Obach SR, Roberts S, Roe A, Shah A, Snikeris F, Sullivan JT, Tweedie D, Vega JM, Walsh J, Wrighton SA; Pharmaceutical Research and Manufacturers of America Drug Metabolism/Clinical Pharmacology Technical Working Groups. Bjornsson TD, et al. J Clin Pharmacol. 2003 May;43(5):443-69. J Clin Pharmacol. 2003. PMID: 12751267 Review.

5

Single-dose pharmacokinetics of nateglinide in subjects with hepatic cirrhosis.

Choudhury S, Hirschberg Y, Filipek R, Lasseter K, McLeod JF. Choudhury S, et al. Among authors: mcleod jf. J Clin Pharmacol. 2000 Jun;40(6):634-40. J Clin Pharmacol. 2000. PMID: 10868314

6

Pharmacokinetics, pharmacodynamics, and safety of microencapsulated octreotide acetate in healthy subjects.

Chen T, Miller TF, Prasad P, Lee J, Krauss J, Miscik K, Kalafsky G, McLeod JF. Chen T, et al. Among authors: mcleod jf. J Clin Pharmacol. 2000 May;40(5):475-81. doi: 10.1177/00912700022009242. J Clin Pharmacol. 2000. PMID: 10806600 Clinical Trial.

7

Tegaserod coadministration does not alter the pharmacokinetics of theophylline in healthy subjects.

Zhou H, Khalilieh S, Svendsen K, Pommier F, Osborne S, Appel-Dingemanse S, Lasseter K, McLeod JF. Zhou H, et al. Among authors: mcleod jf. J Clin Pharmacol. 2001 Sep;41(9):987-93. doi: 10.1177/00912700122010979. J Clin Pharmacol. 2001. PMID: 11549104 Clinical Trial.

8

The effect of food on the oral bioavailability and the pharmacodynamic actions of the insulinotropic agent nateglinide in healthy subjects.

Karara AH, Dunning BE, McLeod JF. Karara AH, et al. Among authors: mcleod jf. J Clin Pharmacol. 1999 Feb;39(2):172-9. doi: 10.1177/00912709922007606. J Clin Pharmacol. 1999. PMID: 11563410 Clinical Trial.

9

The effects of tegaserod (HTF 919) on the pharmacokinetics and pharmacodynamics of digoxin in healthy subjects.

Zhou H, Horowitz A, Ledford PC, Hubert M, Appel-Dingemanse S, Osborne S, McLeod JF. Zhou H, et al. Among authors: mcleod jf. J Clin Pharmacol. 2001 Oct;41(10):1131-9. doi: 10.1177/00912700122012625. J Clin Pharmacol. 2001. PMID: 11583482 Clinical Trial.

10

Mealtime glucose regulation by nateglinide in type-2 diabetes mellitus.

Walter YH, Spratt DI, Garreffa S, McLeod JF. Walter YH, et al. Among authors: mcleod jf. Eur J Clin Pharmacol. 2000 May;56(2):129-33. doi: 10.1007/s002280050730. Eur J Clin Pharmacol. 2000. PMID: 10877006 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters